Yishan Li - Executive Chairman, Director, 10%+ Owner at BlossomHill Therapeutics, Inc.

Issuer-level insider activity

Role
Executive Chairman, Director, 10%+ Owner
Issuer ticker
BLSM
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Yishan Li since 01 Sep 2025

Reported holdings for Yishan Li in BlossomHill Therapeutics, Inc.

Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,714,117
Estimated value
Report date
10 Aug 2026
Price
Ownership
By The Li and Cui Family Trust
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,067,121
Estimated value
Report date
06 Aug 2026
Price
Ownership
By Spouse
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Common Stock
Shares / value
124,779
Estimated value
Report date
10 Aug 2026
Price
Ownership
By RongShan, LLC
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
112,701
Estimated value
Report date
06 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Series Angel Preferred Stock
Shares / value
0
Estimated value
Report date
10 Aug 2026
Price
Ownership
By The Li and Cui Family Trust
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
10 Aug 2026
Price
Ownership
By RongShan, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
10 Aug 2026
Price
Ownership
By The Li and Cui Family Trust
Underlying class
Common Stock
Underlying amount

Transaction history for Yishan Li in BlossomHill Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .